Reimagining Growth with Resilience

Executive summary: FY22 $ 2 Revenue & Scale Profitability & Cost Growth 16% Individual WRP % FY22 27.4% Market Share New Business Margin (NBM) FY21 26.1% 14.8% ***** Customer & Capital FY22 92% 13th month persistency² FY21 90% Rs (Bn.) 218.1 Rs (Bn.) 26.8 Overall 99.6% Renewal premium VNB Claim settlement ratio Growth 18% Growth 22% Individual 98.7% Rs (Bn.) 2,041.7 Rs (Bn.) 12.1 CY 34 AUM Growth 17% Profit After Tax (PAT) Complaints per 10K policies Growth (11%) PY 35 Rs (Bn.) 300.5 CY 12.3% Mar'22 176% IEV1 Operating Solvency EVOP1 16.6% exp. ratio PY 12.0% Dec'21 190% 12 1. Indian Embedded Value: Includes impact of excess mortality reserve (EMR); Pre-EMR EVOP is 19.0%; Excludes Exide Life's EV of Rs 29.1 bn 2. Includes single premium HDFC Life

View entire presentation